[1]Morikawa T,Baba Y,Yamauchi M,et al.STAT3 expression,molecular features,inflammation patterns,and prognosis in a database of 724 colorectal cancers[J].Clinical Cancer Research,2011,17(6):1452-1462.
[2]Liang C,Xu Y,Ge H,et al.Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma[J].OncoTargets and Therapy,2018,11:1203-1214.
[3]Cui X,Jing X,Yi Q,et al.Systematic analysis of gene expression alterations and clinical outcomes of STAT3 in cancer[J].Oncotarget,2018,9(3):3198-3213.
[4]Gordziel C,Bratsch J,Moriggl R,et al.Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma[J].British Journal of Cancer,2013,109(1):138-146.
[5]Yakata Y,Nakayama T,Yoshizaki A,et al.Expression of p-STAT3 in human gastric carcinoma:Significant correlation in tumour invasion and prognosis[J].Int J Oncol,2007,30(2):437-442.
[6]Liu Y,Huang J,Li W,et al.Meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with breast cancer[J].Oncotarget,2018,9(16):13060-13067.
[7]Ito N,Eto M,Nakamura E,et al.STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma[J].J Clin Oncol,2007,25(19):2785-2791.
[8]Wang J,Chuang K,Ahluwalia M,et al.High-throughput SNP genotyping by single-tube PCR with Tm-shift primers[J].Biotechniques,2005,39(6):885-893.
[9]Huang Y,Wang J,Cao F,et al.SHP2 associates with nuclear localization of STAT3:Significance in progression and prognosis of colorectal cancer[J].Scientific Reports,2017,7(1):17597-17603.
[10]Liu Y,Gong W,Yang ZY,et al.Quercetin induces protective autophagy and apoptosis through ER stress via the P-STAT3/Bcl-2 axis in ovarian cancer[J].Apoptosis,2017,22(4):544-557.
[11]Wang G,Jing Y,Cao L,et al.A novel synthetic Asiatic acid derivative induces apoptosis and inhibits proliferation and mobility of gastric cancer cells by suppressing STAT3 signaling pathway[J].OncoTargets Therapy,2017,10:55-66.
[12]Zhong B,Liu Q,Liu Y,et al.Expressions of STAT3,p-STAT3 and E-cadherin in colorectal cancer and clinical implications[J].Chinese Journal of Gastrointestinal Surgery,2014,17(6):594-597.
[13]Kortylewski M,Yu H.Stat3 as a potential target for cancer immunotherapy[J].J Immunother,2007,30(2):131-139.
[14]Wang SW,Sun YM.The IL-6/JAK/STAT3 pathway:potential therapeutic strategies in treating colorectal cancer (review)[J].International Journal of Oncology,2014,44(4):1032-1040.
[15]Siveen KS,Sikka S,Surana R,et al.Targeting the STAT3 signaling pathway in cancer:role of synthetic and natural inhibitors[J].Biochimica et Biophysica Acta,2014,1845(2):136-154.
[16]Han C,Sun B,Zhao X,et al.Phosphorylation of STAT3 promotes vasculogenic mimicry by inducing epithelial-to-mesenchymal transition in colorectal cancer[J].Technology in Cancer Research & Treatment,2017,16(6):1209-1219.